NCT04050436 Study Evaluating Cemiplimab Alone and Combined With RP1 in Treating Advanced Squamous Skin Cancer Status ACTIVE_NOT_RECRUITING Phase PHASE2
NCT04046107 Safety and Immunotherapeutic Activity of Cemiplimab in Participants With HBV on Suppressive Antiviral Therapy Status WITHDRAWN Phase PHASE1/PHASE2
NCT04033367 SAR231893-LPS15497- "Dupilumab Effect on Sleep in AD Patients" Status COMPLETED Phase PHASE4
NCT04015180 Extension Study to Evaluate the Long-term Outcomes of Subjects in Study 20090 Status COMPLETED Phase PHASE3
NCT04004208 Aflibercept for Retinopathy of Prematurity - Intravitreal Injection Versus Laser Therapy Status COMPLETED Phase PHASE3
NCT03992417 Observational Study of Patients Receiving Dupixent® for Atopic Dermatitis (AD) Status ACTIVE_NOT_RECRUITING Phase N/A
NCT03972657 A Trial to Find Out if REGN5678 (Nezastomig) is Safe and How Well it Works Alone or in Combination With Cemiplimab for Adult Participants With Metastatic Castration-Resistant Prostate Cancer and Other Tumors Status RECRUITING Phase PHASE1/PHASE2
NCT03969849 Study to Assess the Safety, Tolerability, Pharmacokinetic, and Pharmacodynamic Effects of a Single Dose of REGN5713-5714-5715 in Healthy Adult Participants Status COMPLETED Phase PHASE1
NCT03969004 Study of Adjuvant Cemiplimab Versus Placebo After Surgery and Radiation Therapy in Patients With High Risk Cutaneous Squamous Cell Carcinoma Status ACTIVE_NOT_RECRUITING Phase PHASE3
NCT03956550 A Study to Examine the Efficacy and Safety of REGN5069 in Patients With Pain Due to Osteoarthritis of the Knee Status TERMINATED Phase PHASE2
NCT03951831 REGN2810 Followed by Chemoimmunotherapy for Newly Metastatic Hormone-sensitive Prostate Cancer Status ACTIVE_NOT_RECRUITING Phase PHASE2
NCT03949673 Study to Evaluate Arthroplasty Specimens for Osteoarthritis of the Knee and Hip Status TERMINATED Phase PHASE2
NCT03946748 Study to Evaluate the Efficacy and Safety of REGN3918 in Patients With Paroxysmal Nocturnal Hemoglobinuria (PNH) Status COMPLETED Phase PHASE2
NCT03936335 An Observational Retrospective Cohort Study Being Conducted in Women With Atopic Dermatitis (AD) Status RECRUITING Phase N/A
NCT03935971 The Effects of Dupilumab on Allergic Contact Dermatitis Status ACTIVE_NOT_RECRUITING Phase PHASE4
NCT03930732 Pivotal Study to Assess the Efficacy, Safety and Tolerability of Dupilumab in Patients With Moderate-to-severe COPD With Type 2 Inflammation Status COMPLETED Phase PHASE3
NCT03916627 Neoadjuvant Cemiplimab for the Treatment of Resectable NSCLC, HCC, and HNSCC in Adult Patients Status ACTIVE_NOT_RECRUITING Phase PHASE2
NCT03912259 Evaluation of Dupilumab in Chinese Adult Patients With Moderate to Severe Atopic Dermatitis Status COMPLETED Phase PHASE3
NCT03889912 Intralesional Cemiplimab for Adult Patients With Cutaneous Squamous Cell Carcinoma or Basal Cell Carcinoma Status COMPLETED Phase PHASE1
NCT03888105 A Study to Assess the Anti-Tumor Activity and Safety of Odronextamab in Adult Patients With B-cell Non-Hodgkin Lymphoma Who Have Been Previously Treated With Other Cancer Therapies Status ACTIVE_NOT_RECRUITING Phase PHASE2